THOC3
gene geneOn this page
Also known as TEX1MGC5469
Summary
THOC3 (THO complex subunit 3, HGNC:19072) is a protein-coding gene on chromosome 5q35.2, encoding THO complex subunit 3 (Q96J01). Component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. It is a common-essential gene (DepMap: required in 99.7% of cancer cell lines).
This gene encodes a component of the nuclear THO transcription elongation complex, which is part of the larger transcription export (TREX) complex that couples messenger RNA processing and export. In humans, the transcription export complex is recruited to the 5’-end of messenger RNAs in a splicing- and cap-dependent manner. Studies of a related complex in mouse suggest that the metazoan transcription export complex is involved in cell differentiation and development. A pseudogene of this gene has been defined on chromosome 5.
Source: NCBI Gene 84321 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 46 total
- Cancer dependency (DepMap): dependent in 99.7% of screened cell lines (common-essential)
- MANE Select transcript:
NM_032361
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19072 |
| Approved symbol | THOC3 |
| Name | THO complex subunit 3 |
| Location | 5q35.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TEX1, MGC5469 |
| Ensembl gene | ENSG00000051596 |
| Ensembl biotype | protein_coding |
| OMIM | 606929 |
| Entrez | 84321 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 15 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000265097, ENST00000432305, ENST00000505969, ENST00000510300, ENST00000511062, ENST00000513006, ENST00000513118, ENST00000513482, ENST00000514250, ENST00000514861, ENST00000515016, ENST00000628318, ENST00000909314, ENST00000909315, ENST00000928777, ENST00000928778, ENST00000928779, ENST00000928780, ENST00000928781, ENST00000960460
RefSeq mRNA: 2 — MANE Select: NM_032361
NM_001376902, NM_032361
CCDS: CCDS4397, CCDS93829
Canonical transcript exons
ENST00000265097 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002467360 | 175959531 | 175960132 |
| ENSE00003459846 | 175961051 | 175961151 |
| ENSE00003557520 | 175964951 | 175965155 |
| ENSE00003618727 | 175961273 | 175961434 |
| ENSE00003681177 | 175967111 | 175967267 |
| ENSE00003899832 | 175967942 | 175968315 |
Expression profiles
Bgee: expression breadth ubiquitous, 143 present calls, max score 96.73.
Top tissues by expression
143 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 96.73 | gold quality |
| esophagus mucosa | UBERON:0002469 | 96.57 | gold quality |
| right testis | UBERON:0004534 | 96.21 | gold quality |
| left testis | UBERON:0004533 | 95.46 | gold quality |
| testis | UBERON:0000473 | 94.98 | gold quality |
| embryo | UBERON:0000922 | 94.01 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.01 | gold quality |
| tonsil | UBERON:0002372 | 93.68 | gold quality |
| lymph node | UBERON:0000029 | 93.25 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.82 | gold quality |
| cerebellum | UBERON:0002037 | 92.52 | gold quality |
| cerebellar cortex | UBERON:0002129 | 92.47 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 92.45 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.17 | gold quality |
| rectum | UBERON:0001052 | 91.88 | gold quality |
| ventricular zone | UBERON:0003053 | 91.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 91.70 | gold quality |
| vagina | UBERON:0000996 | 91.62 | gold quality |
| cortical plate | UBERON:0005343 | 91.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 91.52 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 91.25 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.99 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 90.93 | gold quality |
| frontal cortex | UBERON:0001870 | 90.60 | gold quality |
| frontal lobe | UBERON:0016525 | 90.60 | gold quality |
| bone marrow | UBERON:0002371 | 90.51 | gold quality |
| stromal cell of endometrium | CL:0002255 | 90.48 | gold quality |
| esophagus | UBERON:0001043 | 90.22 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 89.88 | gold quality |
| placenta | UBERON:0001987 | 89.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 14.51 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 99.7% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 2)
- recruitment of the human TREX complex to spliced mRNA is not directly coupled to transcription, but is instead coupled to transcription indirectly through splicing (PMID:15998806)
- THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification. (PMID:37500615)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | thoc3 | ENSDARG00000056517 |
| mus_musculus | Thoc3 | ENSMUSG00000025872 |
| rattus_norvegicus | Thoc3 | ENSRNOG00000000104 |
| drosophila_melanogaster | tex | FBGN0037569 |
Protein
Protein identifiers
THO complex subunit 3 — Q96J01 (reviewed: Q96J01)
Alternative names: TEX1 homolog, hTREX45
All UniProt accessions (8): D6REC9, D6RGZ2, Q96J01, H0Y9T1, H0YA11, H0YAG7, H0YAJ0, H7C0C5
UniProt curated annotations — full annotation on UniProt →
Function. Component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. Required for efficient export of polyadenylated RNA and spliced mRNA. The THOC1-THOC2-THOC3 core complex alone is sufficient to bind export factor NXF1-NXT1 and promote ATPase activity of DDX39B. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5’ end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NXF1 pathway. (Microbial infection) The TREX complex is essential for the export of Kaposi’s sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production.
Subunit / interactions. Component of the THO subcomplex, which is composed of THOC1, THOC2, THOC3, THOC5, THOC6 and THOC7. The THO subcomplex interacts with DDX39B to form the THO-DDX39B complex which multimerizes into a 28-subunit tetrameric assembly. Component of the transcription/export (TREX) complex at least composed of ALYREF/THOC4, DDX39B, SARNP/CIP29, CHTOP and the THO subcomplex; in the complex interacts with THOC2. TREX seems to have a dynamic structure involving ATP-dependent remodeling.
Subcellular location. Nucleus. Nucleus speckle.
Similarity. Belongs to the THOC3 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96J01-1 | 1 | yes |
| Q96J01-2 | 2 |
RefSeq proteins (2): NP_001363831, NP_115737* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR020472 | WD40_PAC1 | Repeat |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR040132 | Tex1/THOC3 | Family |
Pfam: PF25174
UniProt features (45 total): strand 27, repeat 6, turn 5, initiator methionine 1, chain 1, splice variant 1, sequence variant 1, helix 1, region of interest 1, modified residue 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7APK | ELECTRON MICROSCOPY | 3.3 |
| 7ZNL | ELECTRON MICROSCOPY | 3.45 |
| 7ZNK | ELECTRON MICROSCOPY | 3.9 |
| 8R7L | ELECTRON MICROSCOPY | 4.12 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96J01-F1 | 91.07 | 0.87 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
8 pathways
| ID | Pathway |
|---|---|
| R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript |
| R-HSA-72187 | mRNA 3’-end processing |
| R-HSA-73856 | RNA Polymerase II Transcription Termination |
| R-HSA-72202 | Transport of Mature Transcript to Cytoplasm |
| R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA |
| R-HSA-73857 | RNA Polymerase II Transcription |
| R-HSA-74160 | Gene expression (Transcription) |
| R-HSA-8953854 | Metabolism of RNA |
MSigDB gene sets: 100 (showing top):
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, GOBP_NUCLEAR_TRANSPORT, REACTOME_MRNA_3_END_PROCESSING, REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_RNA_SPLICING, GOBP_NUCLEAR_EXPORT, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_RNA_LOCALIZATION, GRADE_COLON_AND_RECTAL_CANCER_UP, REACTOME_METABOLISM_OF_RNA, GOCC_TRANSCRIPTION_EXPORT_COMPLEX, GOCC_NUCLEAR_SPECK, GOCC_CHROMOSOMAL_REGION, GOCC_NUCLEAR_BODY
GO Biological Process (4): mRNA processing (GO:0006397), mRNA export from nucleus (GO:0006406), RNA splicing (GO:0008380), mRNA transport (GO:0051028)
GO Molecular Function (2): RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (7): transcription export complex (GO:0000346), THO complex part of transcription export complex (GO:0000445), nucleoplasm (GO:0005654), nuclear speck (GO:0016607), chromosome, telomeric region (GO:0000781), nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | 2 |
| Transport of Mature Transcript to Cytoplasm | 1 |
| RNA Polymerase II Transcription | 1 |
| Metabolism of RNA | 1 |
| Gene expression (Transcription) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA processing | 2 |
| cellular anatomical structure | 2 |
| mRNA metabolic process | 1 |
| RNA export from nucleus | 1 |
| gene expression | 1 |
| mRNA transport | 1 |
| RNA transport | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| nuclear protein-containing complex | 1 |
| transcription export complex | 1 |
| THO complex | 1 |
| nuclear lumen | 1 |
| nuclear ribonucleoprotein granule | 1 |
| chromosomal region | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
960 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| THOC3 | THOC2 | Q8NI27 | 999 |
| THOC3 | THOC1 | Q96FV9 | 999 |
| THOC3 | DDX39B | Q13838 | 998 |
| THOC3 | THOC5 | Q13769 | 997 |
| THOC3 | THOC7 | Q6I9Y2 | 997 |
| THOC3 | THOC6 | Q86W42 | 997 |
| THOC3 | CYLD | Q9NQC7 | 989 |
| THOC3 | GLI2 | P10070 | 986 |
| THOC3 | ALYREF | Q86V81 | 963 |
| THOC3 | SARNP | P82979 | 846 |
| THOC3 | NXF1 | Q9UBU9 | 750 |
| THOC3 | TEX2 | Q8IWB9 | 670 |
| THOC3 | FYTTD1 | Q96QD9 | 665 |
| THOC3 | CHTOP | Q9Y3Y2 | 631 |
| THOC3 | NCBP3 | Q53F19 | 628 |
IntAct
66 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DDX39B | THOC5 | psi-mi:“MI:0915”(physical association) | 0.800 |
| CCT2 | TXNDC9 | psi-mi:“MI:0914”(association) | 0.730 |
| THOC1 | EIF4A3 | psi-mi:“MI:0914”(association) | 0.660 |
| THOC1 | DDX39A | psi-mi:“MI:0914”(association) | 0.640 |
| THOC3 | CLUH | psi-mi:“MI:0914”(association) | 0.530 |
| NCBP3 | SAP18 | psi-mi:“MI:0914”(association) | 0.530 |
| CCT7 | PEX7 | psi-mi:“MI:0914”(association) | 0.530 |
| EIF4A3 | psi-mi:“MI:0915”(physical association) | 0.490 | |
| DDX21 | MED19 | psi-mi:“MI:2364”(proximity) | 0.480 |
| CHTOP | SAP18 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NUDCD2 | THOC3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| THOC3 | DLG4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| THOC3 | MLKL | psi-mi:“MI:0915”(physical association) | 0.370 |
| TK1 | THOC3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| THOC2 | psi-mi:“MI:0914”(association) | 0.350 | |
| THOC1 | TARS3 | psi-mi:“MI:0914”(association) | 0.350 |
| THOC5 | MYO1G | psi-mi:“MI:0914”(association) | 0.350 |
| THOC7 | ALYREF | psi-mi:“MI:0914”(association) | 0.350 |
| BCLAF1 | PABPN1 | psi-mi:“MI:0914”(association) | 0.350 |
| Srsf1 | SRRM1 | psi-mi:“MI:0914”(association) | 0.350 |
| ANKRD28 | psi-mi:“MI:0914”(association) | 0.350 | |
| KSR1 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| KSR1 | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| KSR1 | FAM168B | psi-mi:“MI:0914”(association) | 0.350 |
| KSR1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (212): PAK2 (Co-fractionation), THOC1 (Co-fractionation), THOC2 (Co-fractionation), THOC3 (Co-fractionation), THOC3 (Co-fractionation), THOC6 (Co-fractionation), THOC3 (Affinity Capture-MS), THOC3 (Affinity Capture-MS), THOC3 (Affinity Capture-MS), THOC3 (Affinity Capture-MS), THOC3 (Affinity Capture-MS), THOC3 (Affinity Capture-MS), THOC1 (Affinity Capture-MS), THOC7 (Affinity Capture-MS), THOC5 (Affinity Capture-MS)
ESM2 similar proteins: A0A1L8EXB5, A4QNE6, A8WGF4, C1BK83, O35142, O43684, O55029, P35605, P35606, Q17QU5, Q1JP79, Q1JQB2, Q29RH4, Q29RZ9, Q3UGF1, Q4FZW5, Q4R4I8, Q561Y0, Q5I0B4, Q5M7F6, Q5MNZ6, Q5R664, Q5RB58, Q5U4Y8, Q5VQ78, Q6GNF1, Q6NWV3, Q6PA72, Q6TGU2, Q803V5, Q8AVT9, Q8BGF3, Q8IWZ6, Q8K2G4, Q8L828, Q8NEZ3, Q8VE80, Q92747, Q96J01, Q96MX6
Diamond homologs: A0JMQ0, A1CQI9, A1D3F5, A2QPZ4, A3LXF0, A4H6F7, A4HUV2, A4IHS2, A4R0Q1, A4RDD7, A5DBG1, A5DWF4, A6QX61, A6RRD4, A6RT32, A6RUL1, A6ZMA9, A7EF03, A8ID74, A8NWR2, A8PWB6, A8QD31, A8XYW9, A9UZS7, B0WC36, B0XQ42, B2AY28, B2VR76, B3MHX6, B3NLK7, B4GIU9, B4HN85, B4J9K1, B4KQU8, B4LKS9, B4MYI5, B4P528, B8M7Q5, B8NGT5, B9WD30
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| THOC3 | “form complex” | “TREX complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 73 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Transport of Mature Transcript to Cytoplasm | 7 | 56.7× | 2e-09 |
| mRNA 3’-end processing | 13 | 54.5× | 1e-17 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | 12 | 38.9× | 2e-14 |
| RNA Polymerase II Transcription Termination | 8 | 37.4× | 2e-09 |
| Processing of Capped Intron-Containing Pre-mRNA | 9 | 15.7× | 2e-07 |
| mRNA Splicing | 5 | 11.7× | 1e-03 |
| mRNA Splicing - Major Pathway | 9 | 10.5× | 7e-06 |
| Metabolism of RNA | 9 | 8.0× | 6e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mRNA export from nucleus | 10 | 47.7× | 4e-12 |
| RNA splicing | 11 | 15.7× | 3e-08 |
| mRNA processing | 11 | 14.0× | 6e-08 |
| mRNA splicing, via spliceosome | 6 | 8.9× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1214 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:175960132:CCT:C | acceptor_loss | 1.0000 |
| 5:175960133:C:A | acceptor_loss | 1.0000 |
| 5:175960134:T:A | acceptor_loss | 1.0000 |
| 5:175961147:CCAGC:C | acceptor_gain | 1.0000 |
| 5:175961148:CAGC:C | acceptor_gain | 1.0000 |
| 5:175961148:CAGCC:C | acceptor_gain | 1.0000 |
| 5:175961149:AGC:A | acceptor_gain | 1.0000 |
| 5:175961150:GC:G | acceptor_gain | 1.0000 |
| 5:175961150:GCC:G | acceptor_loss | 1.0000 |
| 5:175961151:CCTA:C | acceptor_gain | 1.0000 |
| 5:175961152:C:CC | acceptor_gain | 1.0000 |
| 5:175961152:C:CG | acceptor_loss | 1.0000 |
| 5:175961152:C:T | acceptor_gain | 1.0000 |
| 5:175961153:T:C | acceptor_loss | 1.0000 |
| 5:175961154:A:AC | acceptor_gain | 1.0000 |
| 5:175961154:A:C | acceptor_gain | 1.0000 |
| 5:175961157:A:AC | acceptor_gain | 1.0000 |
| 5:175961157:A:C | acceptor_gain | 1.0000 |
| 5:175961160:CAGAG:C | acceptor_gain | 1.0000 |
| 5:175961161:A:T | acceptor_gain | 1.0000 |
| 5:175961164:G:C | acceptor_gain | 1.0000 |
| 5:175961164:G:GC | acceptor_gain | 1.0000 |
| 5:175961169:C:CT | acceptor_gain | 1.0000 |
| 5:175961269:TTACC:T | donor_loss | 1.0000 |
| 5:175961270:TACCT:T | donor_loss | 1.0000 |
| 5:175961271:A:AC | donor_gain | 1.0000 |
| 5:175961271:AC:A | donor_gain | 1.0000 |
| 5:175961272:C:CC | donor_gain | 1.0000 |
| 5:175961272:CC:C | donor_gain | 1.0000 |
| 5:175961338:T:TA | donor_gain | 1.0000 |
AlphaMissense
2350 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:175960080:C:A | W315C | 1.000 |
| 5:175960080:C:G | W315C | 1.000 |
| 5:175960082:A:G | W315R | 1.000 |
| 5:175960082:A:T | W315R | 1.000 |
| 5:175960085:C:G | A314P | 1.000 |
| 5:175961084:C:G | D287H | 1.000 |
| 5:175961090:A:G | S285P | 1.000 |
| 5:175961092:G:T | A284E | 1.000 |
| 5:175961098:G:T | A282E | 1.000 |
| 5:175961121:G:C | F274L | 1.000 |
| 5:175961121:G:T | F274L | 1.000 |
| 5:175961122:A:G | F274S | 1.000 |
| 5:175961123:A:G | F274L | 1.000 |
| 5:175961133:T:A | R270S | 1.000 |
| 5:175961133:T:G | R270S | 1.000 |
| 5:175961311:C:A | W251C | 1.000 |
| 5:175961311:C:G | W251C | 1.000 |
| 5:175961312:C:G | W251S | 1.000 |
| 5:175961313:A:G | W251R | 1.000 |
| 5:175961313:A:T | W251R | 1.000 |
| 5:175961315:A:G | L250P | 1.000 |
| 5:175961321:A:T | V248D | 1.000 |
| 5:175961328:C:G | A246P | 1.000 |
| 5:175961330:T:A | D245V | 1.000 |
| 5:175961331:C:G | D245H | 1.000 |
| 5:175961335:A:C | S243R | 1.000 |
| 5:175961335:A:T | S243R | 1.000 |
| 5:175961336:C:A | S243I | 1.000 |
| 5:175961337:T:G | S243R | 1.000 |
| 5:175961339:C:T | G242E | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1002031700 (5:175968941 A>G), RS1003702495 (5:175962218 T>C), RS1003744992 (5:175962835 A>G), RS1007937640 (5:175960591 G>A), RS1008021935 (5:175966375 C>G), RS1008340533 (5:175959567 A>G,T), RS1010776544 (5:175967011 T>C), RS1011213376 (5:175968531 T>G), RS1012864460 (5:175960772 G>A), RS1012927901 (5:175962682 G>A), RS1015042995 (5:175962240 C>T), RS1015064385 (5:175962961 T>G), RS1018230572 (5:175963868 T>A,C), RS1019257804 (5:175960707 A>G), RS1019329616 (5:175964826 T>C)
Disease associations
OMIM: gene MIM:606929 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007576_353 | Chronotype | 2.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases expression | 2 |
| sodium arsenite | increases expression, decreases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| 4-aminophenylarsenoxide | affects binding, decreases reaction | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Arsenic Trioxide | affects binding, decreases reaction | 1 |
| Acetaminophen | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ivermectin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2II | Abcam HeLa THOC3 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.